课题基金 / 基金详情

FACTOR V LEIDEN PATIENTS WITH CORONARY ARTERY VEIN GRAFT OCCLUSION

FACTOR V LEIDEN PATIENTS WITH CORONARY ARTERY VEIN GRAFT OCCLUSION
冠状动脉静脉移植物闭塞的 V 因子 LEIDEN 患者
批准号:
6282780
负责人:
DAVID McLeod HERRINGTON
金额:
$3.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

DAVID McLeod HERRINGTON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Based on the primary hypothesis that prevalence of the Factor V Leiden mutation will be higher in patients with vein graft occlusions than in those without, this pilot study seeks to estimate the prevalence of the mutation in 100 patients w/ 100 patients without angiographically proven vein graft occlusion. The presence of the mutation is strongly associated w/ deep venous but not arterial thrombotic events. If the association can be established with greater risk of veingraft failure, an argument could be made to avoid vein grafts in pts w/ the mutation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genomic and Proteomic Architecture of Atherosclerosis
Genomic and Proteomic Architecture of Atherosclerosis
Genomic and Proteomic Architecture of Atherosclerosis
Genomic and Proteomic Architecture of Atherosclerosis